Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Major amputation for soft-tissue sarcoma.

M A Clark1, J M Thomas

  • 1Melanoma and Sarcoma Unit, Royal Marsden Hospital, Fulham Road, Chelsea, London SW3 6JJ, UK.

The British Journal of Surgery
|January 10, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Residents'corner June 2015. DeRmpath & Clinic - Immunobullous Disease.

European journal of dermatology : EJD·2015
Same author

Outcome following resection of retroperitoneal sarcoma.

The British journal of surgery·2015
Same author

Isolated Limb Perfusion with Melphalan and Tumour Necrosis Factor α for In-Transit Melanoma and Soft Tissue Sarcoma.

Annals of surgical oncology·2015
Same author

Effects of awareness that food intake is being measured by a universal eating monitor on the consumption of a pasta lunch and a cookie snack in healthy female volunteers.

Appetite·2015
Same author

Surgical treatment of gastrointestinal stromal tumour of the rectum in the era of imatinib.

The British journal of surgery·2015
Same author

[Euthanasia and general practice in Belgium].

Revue medicale de Bruxelles·2015
Same journal

Trimester-Specific Safety of Laparoscopic versus Open Abdominal Surgery During Pregnancy: A Systematic Review and Meta-analysis.

The British journal of surgery·2026
Same journal

The Gut Microbiome in Surgical Oncology: Mechanisms, Perioperative Outcomes, and Therapeutic Opportunities.

The British journal of surgery·2026
Same journal

Patient-led, home-based follow-up for colorectal cancer: the DISTANCE multicentre stepped-wedge cluster-randomised trial.

The British journal of surgery·2026
Same journal

Correction to: Reduced secretory efficiency in parathyroid carcinoma: diagnostic value of the PTH-to-tumour-volume ratio.

The British journal of surgery·2026
Same journal

Global disparities in hepatocellular carcinoma outcomes: multicentre study.

The British journal of surgery·2026
Same journal

Surgical Outcomes from Nationwide Implementation of the International Best-Practice for Locally Advanced Pancreatic Cancer (PREOPANC-4) study.

The British journal of surgery·2026
See all related articles

Major amputation is a valuable surgical option for soft-tissue sarcoma, particularly for recurrent or unresectable tumors. This study found no operative mortality, with many patients achieving disease-free survival post-procedure.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Orthopedic Oncology

Background:

  • Major amputations for soft-tissue sarcoma are infrequent but remain crucial for curative and palliative care.
  • Advances in oncological practice have shifted treatment paradigms, reducing the need for amputation.

Purpose of the Study:

  • To evaluate the outcomes of major amputations in patients with soft-tissue sarcoma.
  • To assess the safety, efficacy, and long-term results of this surgical procedure.

Main Methods:

  • Retrospective review of 40 major amputations (forequarter, hindquarter, hip disarticulation) from a prospective sarcoma database.
  • Analysis of patient case notes, including tumor characteristics, surgical details, and follow-up data.

Main Results:

Related Experiment Videos

  • Forty major amputations were performed over 10 years, primarily for recurrent disease after limb-sparing surgery.
  • Tumors were often large, high-grade, multifocal, or involved neurovascular structures, precluding limb salvage.
  • Zero 30-day operative mortality; median hospital stay varied by amputation level.
  • Local recurrence occurred in 10 patients; 27 patients were alive at 12 months median follow-up (20 disease-free).

Conclusions:

  • Major amputation is a safe and effective procedure in carefully selected soft-tissue sarcoma patients.
  • It offers a viable option for managing complex or recurrent cases where limb salvage is not feasible.